Literature DB >> 1468421

Penetration of pefloxacin into maxillary sinus cavity and nasal secretions.

G Petrikkos1, P Goumas, E Moschovakis, H Giamarellou.   

Abstract

The ability of oral pefloxacin to penetrate into maxillary sinus cavity and nasal secretions was studied in 39 patients suffering from an exacerbation of chronic maxillary sinusitis. The mean levels of pefloxacin in sinus aspirate fluid 0, 3, 6, 9 and 12 h after the second oral dose of 400 mg were 2.30, 6.92, 3.74, 3.47 and 2.82 mg/l respectively. In sinus cystic fluid (macroscopically non-purulent) the mean pefloxacin levels were 2.30, 7.15, 4.20 and 4.15 mg/l respectively, and in nasal secretion 1.90, 9.05, 3.71, 3.20 and 2.85 mg/l respectively. The mean pefloxacin levels in serum obtained simultaneously were 1.50, 5.00, 3.10, 2.70 and 2.20 mg/l respectively. It is concluded that pefloxacin accumulates in inflamed sinus fluid at concentrations exceeding blood levels.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1468421     DOI: 10.1007/bf01960883

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  17 in total

1.  Antistaphylococcal activity of the fluoroquinolones CI-960, PD 131628, sparfloxacin, ofloxacin and ciprofloxacin.

Authors:  A L Barry; P C Fuchs
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-03       Impact factor: 3.267

2.  Penetration of erythromycin stearate into maxillary sinus mucosa and secretion in chronic maxillary sinusitis.

Authors:  M Paavolainen; A Kohonen; T Palva; O V Renkonen
Journal:  Acta Otolaryngol       Date:  1977 Sep-Oct       Impact factor: 1.494

Review 3.  The runny nose. Infection of the paranasal sinuses.

Authors:  C L Daley; M Sande
Journal:  Infect Dis Clin North Am       Date:  1988-03       Impact factor: 5.982

4.  The concentration of antibiotics in sinus secretions. Ampicillin, cephradine and erythromycinestolate.

Authors:  A Axelsson; J E Brorson
Journal:  Ann Otol Rhinol Laryngol       Date:  1974 May-Jun       Impact factor: 1.547

5.  Concentration of antibiotics in sinus secretions. Doxycycline and spiramycin.

Authors:  A Axelsson; J E Brorson
Journal:  Ann Otol Rhinol Laryngol       Date:  1973 Jan-Feb       Impact factor: 1.547

6.  Localization of bacteria and the cause of tissue destruction in maxillary sinusitis.

Authors:  C Lundberg; S Engquist
Journal:  Acta Otolaryngol Suppl       Date:  1984

7.  Pefloxacin versus ceftazidime in the treatment of a variety of gram-negative-bacterial infections.

Authors:  H Giamarellou; G Perdikaris; N Galanakis; G Davoulos; K Mandragos; P Sfikakis
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

Review 8.  Quinolones in perspective.

Authors:  H C Neu
Journal:  J Antimicrob Chemother       Date:  1990-10       Impact factor: 5.790

9.  Pefloxacin versus imipenem in the therapy of nosocomial lung infections of intensive care unit patients.

Authors:  H Giamarellou; K Mandragos; P Bechrakis; K Pigas; D Bilalis; P Sfikakis
Journal:  J Antimicrob Chemother       Date:  1990-10       Impact factor: 5.790

10.  In-vitro activity of newer quinolones against aerobic bacteria.

Authors:  R Auckenthaler; M Michéa-Hamzehpour; J C Pechère
Journal:  J Antimicrob Chemother       Date:  1986-04       Impact factor: 5.790

View more
  1 in total

Review 1.  Pefloxacin clinical pharmacokinetics.

Authors:  F Bressolle; F Gonçalves; A Gouby; M Galtier
Journal:  Clin Pharmacokinet       Date:  1994-12       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.